Top Markets
Coin of the day
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.

NeuBase Therapeutics, Inc.

NBSE
Classificação em ações #39173
Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics,... Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics, Inc. is dedicated to pioneering therapeutic solutions for rare genetic disorders and various cancers stemming from aberrant genes. At the core of its approach is the proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform. This technology is being utilized to target ailments such as Huntington's disease (HD) and myotonic dystrophy, in addition to a broader spectrum of genetic conditions and applications within oncology. The company's leading therapeutic candidates encompass NT0100, a PATrOL-powered anti-gene therapy for Huntington's disease; NT0200, another PATrOL-enabled anti-gene solution for myotonic dystrophy type 1; and NT0300, a PATrOL-based treatment specifically engineered to address the mutated KRAS gene. NeuBase Therapeutics, Inc. maintains its headquarters in Pittsburgh, Pennsylvania.
Preço da ação
$0.378
Última sincronização: 2024-05-24
Valor de mercado
$618.41K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar NeuBase Therapeutics, Inc. (NBSE)

Categoria

Histórico de preços das ações de NeuBase Therapeutics, Inc. (NBSE)
Preço de fecho mais alto: $0.39 em 2024-05-01

Preço de fecho mais baixo: $733.33 em 2004-05-01
Histórico de preços das ações da NeuBase Therapeutics, Inc. de 2004 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2024 -49.90%
2023 -81.22%
2022 -92.72%
2021 -64.02%
2020 7.86%
2019 205.09%
2018 -92.38%
2017 -19.09%
2016 -60.75%
2015 75.31%
2014 6.31%
2013 49.44%
2012 167.16%
2011 169.72%
2010 -59.63%
2009 129.24%
2008 14.29%
2007 -48.15%
2006 -74.29%
2005 -15.32%
2004 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$517.18 32.51%
US
$857.76 31.47%
NL
$731.95 7.17%
CH
$1.07K -6.40%
KR
$257.04 13.55%
BE